What's new

Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 35, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 35, Status: Authorised

Apr 8, 2025 - 15:52
 0
Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 35, Status: Authorised
Human medicines European public assessment report (EPAR): Pregabalin Viatris Pharma (previously Pregabalin Pfizer), pregabalin, Date of authorisation: 10/04/2014, Revision: 35, Status: Authorised
Read More

Tags:

Previous Article

Fierce Biotech Fundraising Tracker '25: Merida debuts with $121M; RayThera raise...

Next Article

Geely Has Launched 48 New Models Since Tesla Revealed the Cybertruck!

Related Posts

Call for scientific data for the periodic review of the...

Apr 1, 2025  0

Human medicines European public assessment report (EPAR): Somavert, pegvisomant, Date of authorisation: 12/11/2002, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Cardiovascular Working Party

Cardiovascular Working Party

Feb 9, 2025  0